Professor Jonathan Blackburn, chief scientific officer
Sengenics seeks strategic partners to advance autoantibody-based diagnostics and therapeutics
- Leveraging its core technology, Sengenics has created Symphoni, the largest database of human autoantibody profiles across multiple ethnicities
Topic |
Singapore National Day Report August 2019
Supported by
Discovery Reports
Professor Jonathan Blackburn, chief scientific officer